ZoneOne Pharma

NIH awards 8

Annual award amounts. Total $3.1M.

• Aug 25, 2016 NIH award 1R43EY027240-01 FY2016: $238,466 awarded for that fiscal year; activity R43 (SBIR); PI NOBLE, CHARLES OAKLEY; recipient as written: ZONEONE PHARMA, INC., SAN FRANCISCO, CA. Non-irritating Sustained Release source ↗
• Apr 26, 2016 NIH award 5R44HD075429-03 FY2016: $956,715 awarded for that fiscal year; activity R44 (SBIR); PI HAYES, MARK EAMON; recipient as written: ZONEONE PHARMA, INC., SAN FRANCISCO, CA. Twice-Weekly Subcutaneous Liposome Ch source ↗
• Apr 3, 2015 NIH award 1R41CA192689-01 FY2015: $298,920 awarded for that fiscal year; activity R41 (STTR); PI SZOKA, FRANCIS C.; recipient as written: ZONEONE PHARMA, INC., SAN FRANCISCO, CA. Retargeting FDA Approved Anticancer L source ↗
• Mar 31, 2015 NIH award 2R44HD075429-02 FY2015: $534,478 awarded for that fiscal year; activity R44 (SBIR); PI HAYES, MARK EAMON; recipient as written: ZONEONE PHARMA, INC., SAN FRANCISCO, CA. Twice-Weekly Subcutaneous Liposome Ch source ↗
• Sep 8, 2014 NIH award 3U01FD004893-01S1 FY2014: $249,996 awarded for that fiscal year; activity U01 (OTHER_NIH); PI WORKING, PETER; recipient as written: ZONEONE PHARMA, INC., SAN FRANCISCO, CA. Development of a Liposome Doxorub source ↗
• Sep 10, 2013 NIH award 1U01FD004893-01 FY2013: $467,811 awarded for that fiscal year; activity U01 (OTHER_NIH); PI WORKING, PETER; recipient as written: ZONEONE PHARMA, INC., SAN FRANCISCO, CA. Development of a Liposome Doxorubic source ↗
• Jul 2, 2013 NIH award 1R43HD075429-01 FY2013: $160,664 awarded for that fiscal year; activity R43 (SBIR); PI HAYES, MARK EAMON; recipient as written: ZONEONE PHARMA, INC., SAN FRANCISCO, CA. Twice-Weekly Subcutaneous Liposome Ch source ↗
• 2012 NIH contract (government contract; not a grant and not an investment round) 261201200082C-0-0-1 FY2012: $215,999 awarded for that fiscal year; activity N43 (OTHER_NIH); PI NOBLE, CHARLES; recipient as written: ZONEONE PHARMA, INC., SAN FRANCISCO, CA. OTHER FUN source ↗